Characterization and management of testicular pathology in McCune-Albright syndrome.

CONTEXT The testicular phenotype in McCune-Albright syndrome (MAS) has not been well characterized. Boys present with a relatively low incidence of precocious puberty in comparison with girls. Radiographic and histological studies are limited to small series and case reports, which report testicular microlithiasis and Sertoli cell hyperplasia. OBJECTIVE Our objective was to characterize the biochemical, radiological, and histological spectrum and clinical management of testicular pathology in males with MAS. PATIENTS, DESIGN, AND SETTING Fifty-four males with MAS participated in this prospective cohort study at a clinical research center. INTERVENTION Evaluation included testicular exam, pubertal staging, testicular ultrasound, measurement of LH, FSH, and testosterone. Orchiectomies were performed when considered clinically indicated. MAIN OUTCOME MEASURE Prevalence and characterization of ultrasound lesions with correlation to histology were evaluated. RESULTS Of 54 males, 44 (81%) presented with ultrasound abnormalities including hyperechoic lesions (49%), hypoechoic lesions (30%), microlithiasis (30%), heterogeneity (47%), and focal calcifications (11%). Eight subjects underwent orchiectomy revealing large foci of Leydig cell hyperplasia, which could not be definitively distinguished from Leydig cell tumor. After no subjects developed clinical malignancy, a conservative approach was instituted, and subsequent subjects were followed with serial imaging. Testosterone and gonadotropins were normal in subjects without precocious puberty or pituitary disease. Eleven (21%) presented with precocious puberty, and a combination of aromatase inhibitors, androgen receptor blockers, and leuprolide resulted in improved predicted adult height. In addition, the first cases of testicular adrenal rest and bilateral germ cell tumors in association with MAS are presented. CONCLUSIONS Contrary to prevailing thinking, the incidence of gonadal pathology in MAS is equal in males and females. The predominant histopathological finding was Leydig cell hyperplasia, which carries a low risk of malignant transformation and can be managed conservatively.

[1]  D. Shulman,et al.  Bicalutamide and Third-Generation Aromatase Inhibitors in Testotoxicosis , 2010, Pediatrics.

[2]  M. Shinawi,et al.  McCune-Albright syndrome presenting with unilateral macroorchidism and bilateral testicular masses , 2010, Pediatric Radiology.

[3]  P. Chanson,et al.  Ovarian dysfunction by activating mutation of GS alpha: McCune-Albright syndrome as a model. , 2010, Annales d'endocrinologie.

[4]  O. Söder,et al.  Origin, Development and Regulation of Human Leydig Cells , 2010, Hormone Research in Paediatrics.

[5]  G. Salzano,et al.  Combined treatment with ketoconazole and cyproterone acetate in a boy with McCune-Albright syndrome and peripheral precocious puberty , 2008, Journal of endocrinological investigation.

[6]  N. Lahlou,et al.  Regulation of spermatogenesis in McCune-Albright syndrome: lessons from a 15-year follow-up. , 2008, European journal of endocrinology.

[7]  M. Collins,et al.  McCune-Albright syndrome , 2008, Orphanet journal of rare diseases.

[8]  P. Bianco,et al.  The role of stem cells in fibrous dysplasia of bone and the Mccune-Albright syndrome. , 2007, Pediatric endocrinology reviews : PER.

[9]  T. Shawker,et al.  Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study. , 2007, The Journal of clinical endocrinology and metabolism.

[10]  J. Regadera,et al.  Leydig cell tumor and hyperplasia: a review. , 2007, Analytical and quantitative cytology and histology.

[11]  R. Rey,et al.  Unexpected mosaicism of R201H-GNAS1 mutant-bearing cells in the testes underlie macro-orchidism without sexual precocity in McCune-Albright syndrome. , 2006, Human molecular genetics.

[12]  O. Leone,et al.  McCune-Albright Syndrome in a Boy May Present with a Monolateral Macroorchidism as an Early and Isolated Clinical Manifestation , 2006, Hormone Research in Paediatrics.

[13]  G. Salzano,et al.  Clinical Presentation of McCune-Albright Syndrome in Males , 2006, Journal of pediatric endocrinology & metabolism : JPEM.

[14]  M. Zacharin.  Paediatric Management of Endocrine Complications in McCune-Albright Syndrome , 2005, Journal of pediatric endocrinology & metabolism : JPEM.

[15]  R. Lala,et al.  Testicular microlithiasis: an unreported feature of McCune-Albright syndrome in males. , 2004, The Journal of pediatrics.

[16]  M. Srivastava.  Carney complex. , 2004, Dermatology online journal.

[17]  S. Rubin,et al.  Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. , 2003, The Journal of pediatrics.

[18]  D. D. de Kretser,et al.  The contributions of deficient androgen action in spermatogenic disorders. , 2003, International journal of andrology.

[19]  David Handelsman,et al.  An activated human follicle-stimulating hormone (FSH) receptor stimulates FSH-like activity in gonadotropin-deficient transgenic mice. , 2002, Molecular endocrinology.

[20]  G. Chrousos,et al.  Future Directions in the Study and Management of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency , 2002, Annals of Internal Medicine.

[21]  G. Cutler,et al.  Nodular Leydig cell hyperplasia in a boy with familial male-limited precocious puberty. , 2001, The Journal of pediatrics.

[22]  R. Rey,et al.  Macroorchidism due to autonomous hyperfunction of Sertoli cells and G(s)alpha gene mutation: an unusual expression of McCune-Albright syndrome in a prepubertal boy. , 2001, The Journal of clinical endocrinology and metabolism.

[23]  S. Wientroub,et al.  Mutations of the GNAS1 Gene, Stromal Cell Dysfunction, and Osteomalacic Changes in Non–McCune–Albright Fibrous Dysplasia of Bone , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  D. Doyle,et al.  Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. , 1999, The New England journal of medicine.

[25]  G. Cutler,et al.  Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset. , 1999, The Journal of clinical endocrinology and metabolism.

[26]  J. Cheville,et al.  Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors. , 1998, The American journal of surgical pathology.

[27]  O. Rennert,et al.  Testicular seminoma in a patient with a constitutively activating mutation of the luteinizing hormone/chorionic gonadotropin receptor. , 1998, European journal of endocrinology.

[28]  A. Latronico,et al.  Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. , 1998, The Journal of clinical endocrinology and metabolism.

[29]  E. Nieschlag,et al.  Functional and clinical consequences of mutations in the FSH receptor , 1996, Molecular and Cellular Endocrinology.

[30]  Feuillan Pp.  McCune-Albright syndrome. , 1994 .

[31]  Robert E. Scully,et al.  Case 7-1993 , 1993 .

[32]  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-1993. A six-year-old boy with multiple bone lesions, repeated fractures, and sexual precocity. , 1993, The New England journal of medicine.

[33]  C. Francomano,et al.  Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Merino,et al.  Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. , 1991, The New England journal of medicine.

[35]  P. Valensi,et al.  Endocrine investigations in two cases of feminizing Leydig cell tumour. , 1987, Acta endocrinologica.

[36]  J. Richardson,et al.  Leydig cell tumor and metachronous Leydig cell hyperplasia: a case associated with gynecomastia and elevated urinary estrogens. , 1986, The Journal of urology.

[37]  T. Shawker,et al.  Ovarian Function in Girls with McCune-Albright Syndrome , 1986, Pediatric Research.

[38]  R. Scully,et al.  Leydig cell tumors of the testis: A clinicopathological analysis of 40 cases and review of the literature , 1985, The American journal of surgical pathology.

[39]  S. Bernasconi,et al.  McCune-Albright syndrome in a male child: a clinical and endocrinologic enigma. , 1978, The Journal of pediatrics.

[40]  P. H. Benedict.  Sex precocity and polyostotic fibrous dysplasia. Report of a case in a boy with testicular biopsy. , 1966, American journal of diseases of children.

[41]  P. Smith,et al.  Syndrome Characterized by Osteitis Fibrosa Disseminata, Areas of Pigmentation and Endocrine Dysfunction, with Precocious Puberty in Females , 1937 .

[42]  C. Mckhann.  SOCIETY FOR PEDIATRIC RESEARCH , 1933 .

[43]  Davies Hm.  Osteitis Fibrosa Cystica. , 1915 .